Cargando…
Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap
The transverse myocutaneous gracilis (TMG) and the profunda artery perforator (PAP) flap are both safe choices for autologous breast reconstruction originating from the same donor region in the upper thigh. We aimed to compare the post-operative outcome regarding donor-site morbidity and quality of...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406532/ https://www.ncbi.nlm.nih.gov/pubmed/36005186 http://dx.doi.org/10.3390/curroncol29080448 |
_version_ | 1784774144298057728 |
---|---|
author | Augustin, Angela Pülzl, Petra Morandi, Evi M. Winkelmann, Selina Schoberleitner, Ines Brunner, Christine Ritter, Magdalena Bauer, Thomas Wachter, Tanja Wolfram, Dolores |
author_facet | Augustin, Angela Pülzl, Petra Morandi, Evi M. Winkelmann, Selina Schoberleitner, Ines Brunner, Christine Ritter, Magdalena Bauer, Thomas Wachter, Tanja Wolfram, Dolores |
author_sort | Augustin, Angela |
collection | PubMed |
description | The transverse myocutaneous gracilis (TMG) and the profunda artery perforator (PAP) flap are both safe choices for autologous breast reconstruction originating from the same donor region in the upper thigh. We aimed to compare the post-operative outcome regarding donor-site morbidity and quality of life. We included 18 patients who had undergone autologous breast reconstruction with a PAP flap (n = 27 flaps). Prospective evaluation of donor-site morbidity was performed by applying the same questionnaire that had already been established in a previous study evaluating TMG flap (n = 25 flaps) outcome, and results were compared. Comparison of the two patient groups showed equivalent results concerning patient-reported visibility of the donor-site scar and thigh symmetry. Still, the TMG group was significantly more satisfied with the scar (p = 0.015) and its position (p = 0.001). No difference was found regarding the ability to sit for prolonged periods. Donor-site wound complications were seen more frequently in the PAP group (29.6%) than in the TMG group (4.0%). Both groups expressed rather high satisfaction with their quality of life. Both flaps show minimal functional donor-site morbidity and high patient satisfaction. To minimize wound healing problems in PAP patients, thorough planning of the skin paddle is necessary. |
format | Online Article Text |
id | pubmed-9406532 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94065322022-08-26 Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap Augustin, Angela Pülzl, Petra Morandi, Evi M. Winkelmann, Selina Schoberleitner, Ines Brunner, Christine Ritter, Magdalena Bauer, Thomas Wachter, Tanja Wolfram, Dolores Curr Oncol Article The transverse myocutaneous gracilis (TMG) and the profunda artery perforator (PAP) flap are both safe choices for autologous breast reconstruction originating from the same donor region in the upper thigh. We aimed to compare the post-operative outcome regarding donor-site morbidity and quality of life. We included 18 patients who had undergone autologous breast reconstruction with a PAP flap (n = 27 flaps). Prospective evaluation of donor-site morbidity was performed by applying the same questionnaire that had already been established in a previous study evaluating TMG flap (n = 25 flaps) outcome, and results were compared. Comparison of the two patient groups showed equivalent results concerning patient-reported visibility of the donor-site scar and thigh symmetry. Still, the TMG group was significantly more satisfied with the scar (p = 0.015) and its position (p = 0.001). No difference was found regarding the ability to sit for prolonged periods. Donor-site wound complications were seen more frequently in the PAP group (29.6%) than in the TMG group (4.0%). Both groups expressed rather high satisfaction with their quality of life. Both flaps show minimal functional donor-site morbidity and high patient satisfaction. To minimize wound healing problems in PAP patients, thorough planning of the skin paddle is necessary. MDPI 2022-08-11 /pmc/articles/PMC9406532/ /pubmed/36005186 http://dx.doi.org/10.3390/curroncol29080448 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Augustin, Angela Pülzl, Petra Morandi, Evi M. Winkelmann, Selina Schoberleitner, Ines Brunner, Christine Ritter, Magdalena Bauer, Thomas Wachter, Tanja Wolfram, Dolores Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap |
title | Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap |
title_full | Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap |
title_fullStr | Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap |
title_full_unstemmed | Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap |
title_short | Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap |
title_sort | donor-site morbidity and quality of life after autologous breast reconstruction with pap versus tmg flap |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406532/ https://www.ncbi.nlm.nih.gov/pubmed/36005186 http://dx.doi.org/10.3390/curroncol29080448 |
work_keys_str_mv | AT augustinangela donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap AT pulzlpetra donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap AT morandievim donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap AT winkelmannselina donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap AT schoberleitnerines donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap AT brunnerchristine donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap AT rittermagdalena donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap AT bauerthomas donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap AT wachtertanja donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap AT wolframdolores donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap |